Morphic Holding Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Morphic Holding last-minute Real Value cannot be determined due to lack of data. The latest price of Morphic Holding is $0.0. Our model forecasts the value of Morphic Holding from analyzing the firm fundamentals such as Return On Equity of -0.27, current valuation of 2.24 B, and Shares Owned By Insiders of 17.12 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
0.00
Please note that Morphic Holding's price fluctuation is out of control at this time. Calculation of the real value of Morphic Holding is based on 3 months time horizon. Increasing Morphic Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Morphic stock is determined by what a typical buyer is willing to pay for full or partial control of Morphic Holding. Since Morphic Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Morphic Stock. However, Morphic Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0 Real  0.0 Hype  0.0 Naive  30.33
The real value of Morphic Stock, also known as its intrinsic value, is the underlying worth of Morphic Holding Company, which is reflected in its stock price. It is based on Morphic Holding's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Morphic Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.00
Real Value
0.00
Upside
Estimating the potential upside or downside of Morphic Holding helps investors to forecast how Morphic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Morphic Holding more accurately as focusing exclusively on Morphic Holding's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
23.5252.8282.13
Details
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Naive
Forecast
LowNext ValueHigh
30.3330.3330.33
Details

Morphic Holding Total Value Analysis

Morphic Holding is now projected to have valuation of 2.24 B with market capitalization of 2.86 B, debt of 2.34 M, and cash on hands of 397.56 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Morphic Holding fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
2.24 B
2.86 B
2.34 M
397.56 M

Morphic Holding Investor Information

About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Morphic Holding was now reported as 12.34. The company recorded a loss per share of 3.83. Morphic Holding had not issued any dividends in recent years. Morphic Holding is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Morphic Holding Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Morphic Holding has an asset utilization ratio of 0.0721 percent. This implies that the Company is making $7.21E-4 for each dollar of assets. An increasing asset utilization means that Morphic Holding is more efficient with each dollar of assets it utilizes for everyday operations.

Morphic Holding Ownership Allocation

Morphic Holding maintains a total of 50.22 Million outstanding shares. The majority of Morphic Holding outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Morphic Holding to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Morphic Holding. Please pay attention to any change in the institutional holdings of Morphic Holding as this could imply that something significant has changed or is about to change at the company. Also note that almost four million eighty-eight thousand two hundred ninety-one invesors are currently shorting Morphic Holding expressing very little confidence in its future performance.

Morphic Holding Profitability Analysis

The company reported the previous year's revenue of 521 K. Net Loss for the year was (152.09 M) with loss before overhead, payroll, taxes, and interest of (31.25 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Morphic Holding's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Morphic Holding and how it compares across the competition.

About Morphic Holding Valuation

The delisted stock valuation mechanism determines Morphic Holding's current worth on a weekly basis. Our valuation model uses a comparative analysis of Morphic Holding. We calculate exposure to Morphic Holding's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Morphic Holding's related companies.
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Morphic Holding operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.

Morphic Holding Growth Indicators

Investing in growth stocks can be very risky. If the company such as Morphic Holding does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding42.4 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Morphic Stock

If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities